Expression of human p53 requires synergistic activation of transcription from the p53 promoter by AP-1, NF-κB and Myc/Max

被引:118
|
作者
Kirch, HC [1 ]
Flaswinkel, S [1 ]
Rumpf, H [1 ]
Brockmann, D [1 ]
Esche, H [1 ]
机构
[1] Univ Essen Gesamthsch, Sch Med, Inst Mol Biol Canc Res, D-45122 Essen, Germany
关键词
p53; promoter; transcription; AP-1; NF-kappa B; Myc/Max;
D O I
10.1038/sj.onc.1202626
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Transcriptional control of p53 expression participates in the generation of appropriate le, els of active p53 in response to mitogenic stimulation, This prompted us to study the role of a putative AP-1 and a NF-kappa B motif in the human p53 promoter for transcriptional regulation, We show that mutation of the AP-1 or the NF-kappa B motif abolishes transcription from the human p53 promoter in HeLa, HepG2 and adenovirus type 5 E1-transformed 293 cells, In comparison, mutation of the previously characterized Myc/Max/USF binding site in the human p53 promoter reduces the transcription rate fivefold. The AP-1 motif in the human p53 promoter binds c-Fos and c-Jun and the NF-kappa-B motif binds p50(NF-kappa B1) and p65(RelA). The cooperative nature of transcriptional activation by these factors was documented by repression of c-fos or NF-kappa B1 translation: Pretreatment of the cells,vith a c-fos or p50(NF-kappa B1) antisense oligonucleotide suppresses transcription from the human p53 promoter completely. In addition, we show that (a) the level of endogenous p53 mRNA and (b) transcription from the strictly p53-dependent human mdm2 promoter are reduced in the presence of c-fos, c-jun, p50(NF-kappa B1), p65(RelA) or c-myc antisense oligonucleotides, underscoring the importance of these transcription factors for the expression of functional p53.
引用
收藏
页码:2728 / 2738
页数:11
相关论文
共 50 条
  • [31] Modeling oscillatory control in NF-κB, p53 and Wnt signaling
    Mengel, Benedicte
    Hunziker, Alexander
    Pedersen, Lykke
    Trusina, Ala
    Jensen, Mogens H.
    Krishna, Sandeep
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2010, 20 (06) : 656 - 664
  • [32] Contribution of NF-κB and p53 in the glutamate-induced apoptosis
    Uberti, D
    Grilli, M
    Memo, M
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (4-5) : 447 - 454
  • [33] ARF the integrator -: Linking NF-κB, p53 and checkpoint kinases
    Rocha, S
    Perkins, ND
    CELL CYCLE, 2005, 4 (06) : 756 - 759
  • [34] Stabilization of p53 is a novel mechanism for proapoptotic function of NF-κB
    Fujioka, S
    Schmidt, C
    Sclabas, GM
    Li, ZK
    Pelicano, H
    Peng, B
    Yao, A
    Niu, JG
    Zhang, W
    Evans, DB
    Abbruzzese, JL
    Huang, P
    Chiao, PJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (26) : 27549 - 27559
  • [35] P53 STIMULATES TRANSCRIPTION FROM THE HUMAN TRANSFORMING GROWTH-FACTOR-ALPHA PROMOTER - A POTENTIAL GROWTH-STIMULATORY ROLE FOR P53
    SHIN, TH
    PATERSON, AJ
    KUDLOW, JE
    MOLECULAR AND CELLULAR BIOLOGY, 1995, 15 (09) : 4694 - 4701
  • [36] TLR1-10, NF-κB and p53 expression is increased in oral lichenoid disease
    Rusanen, Peter
    Marttila, Emilia
    Uittamo, Johanna
    Hagstrom, Jaana
    Salo, Tuula
    Rautemaa-Richardson, Riina
    PLOS ONE, 2017, 12 (07):
  • [37] INVITRO EXPRESSION OF HUMAN P53 CDNA CLONES AND CHARACTERIZATION OF THE CLONED HUMAN P53 GENE
    WOLF, D
    LAVERRUDICH, Z
    ROTTER, V
    MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (08) : 1887 - 1893
  • [38] Oscillatory expression of Hes1, p53, and NF-κB driven by transcriptional time delays
    Monk, NAM
    CURRENT BIOLOGY, 2003, 13 (16) : 1409 - 1413
  • [39] Actvation of NF-κB by the API2/MALT1 fusions inhibits p53 dependant but not FAS induced apoptosis -: A directional link between NF-κB and p53
    Stoffel, A
    Levine, AJ
    CELL CYCLE, 2004, 3 (08) : 1017 - 1020
  • [40] p53 gene mutations and p53 protein expression in human soft tissue sarcomas
    Yoo, JY
    Lee, HK
    Kang, CS
    Park, WS
    Lee, JY
    Shim, SI
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1997, 121 (04) : 395 - 399